Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
<h3>Background</h3><p>Baló concentric sclerosis (BCS) is a rare demyelinating disorder that overlaps with other demyelinating diseases. BCS usually present in the context of multiple sclerosis (MS) or preceding typical MS. It rarely presents as an isolated lesion, . IV methyl predn...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| الملخص: | <h3>Background</h3><p>Baló concentric sclerosis (BCS) is a rare demyelinating disorder that overlaps with other demyelinating diseases. BCS usually present in the context of multiple sclerosis (MS) or preceding typical MS. It rarely presents as an isolated lesion, . IV methyl prednisolone (IVMP) is the mainstay in the treatment with various outcomes. Maintenance therapy is still not clearly defined. Case presentation/case report: We present a case of isolated BCS that responded clinically and radiologically to long-term rituximab therapy.</p><h3>Conclusion</h3><p>A definite guideline for treating patient with BCS either with MS or as isolated entity is still controversial. Our case reflects a remarkable response to rituximab in achieving clinical and radiological longterm remission.</p><h2>Other Information</h2><p>Published in: Neuroimmunology Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" rel="noreferrer" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.nerep.2023.100177" target="_blank">https://dx.doi.org/10.1016/j.nerep.2023.100177</a></p> |
|---|